S23-384 Encapsulation and Local Delivery of Inhibitors of the Activator Protein 1 (AP-1) for Preventing Adhesions Stanford scientists have developed a novel hydrogel for long-term drug delivery of an Activator Protein 1 (AP-1) inhibitor for the prevention of post-surgical abdominal adhesion. Michael Longaker Eric Appel Deshka Foster Jason Guo Daniel Delitto Emily Meany Jeffrey Norton Ye Eun SONG
S19-317 A Machine Learning Algorithm for Analysis of Connective Tissue Networks in Scarring and Chronic Fibroses The Longaker lab at Stanford University has developed a machine learning algorithm that can analyze and detect fibrotic disease. Shamik Mascharak Heather Talbott Mimi Borrelli Alessandra Moore Michael Longaker
S23-082 The use of mechanotransduction inhibitors as a coating for surgical sutures to reduce scarring Researchers at Stanford have proposed that coating surgical sutures with mechanotransduction inhibitors may reduce scarring of the tissue. Michelle Griffin Michael Longaker Shamik Mascharak Michael Januszyk Heather Talbott Michael Davitt Geoffrey Gurtner Derrick Wan
S19-533 Use of Small Molecule Inhibitor for Preventing Abdominal Adhesions Researchers at Stanford have identified a novel method of use for the drug T-5224 in the prevention of abdominal adhesion. Michael Longaker Gerlinde Wernig Jeffrey Norton Geoffrey Gurtner Michael Januszyk Deshka Foster Malini Chinta